absorb.md

OpenAI

Chronological feed of everything captured from OpenAI.

OpenAI Releases GPT-5.5 and Pro Variant in API with Enhanced Intelligence and Efficiency

OpenAI has launched GPT-5.5 and GPT-5.5 Pro models in its API. These models deliver higher intelligence for complex tasks and improved token efficiency, reducing the need for retries. They target advanced workflows requiring fewer iterations.

GPT-5.5 Advances Agentic AI with Superior Task Completion and Efficiency

GPT-5.5 introduces enhanced intelligence for complex goals, tool usage, self-verification, and sustained task execution, excelling in agentic coding, computer use, knowledge work, and scientific research. It matches GPT-5.4's per-token latency while outperforming on evaluations and using fewer tokens for Codex tasks. Full-stack inference optimizations make it faster and more practical for demanding workloads in ChatGPT and Codex, available now to Plus, Pro, Business, and Enterprise users.

GPT-5.5 Advances Agentic Intelligence with Uncompromised Speed and Efficiency

GPT-5.5 introduces a new intelligence class optimized for complex goals, tool usage, self-verification, and task completion in agentic coding, computer use, knowledge work, and scientific research. It matches GPT-5.4's per-token latency while outperforming on evaluations and using fewer tokens for Codex tasks. Full-stack inference enhancements make it faster and more practical for Pro users, enabling high-quality handling of demanding workflows.

GPT-5.5 Boosts Intelligence and Efficiency Without Speed Trade-offs

GPT-5.5 achieves superior intelligence over GPT-5.4 while matching its per-token latency in production serving. It outperforms GPT-5.4 across nearly all measured evaluations. Additionally, it completes identical Codex tasks with substantially fewer tokens, enhancing overall efficiency.

GPT-5.5 Advances Agentic AI with Superior Reasoning, Tool Use, and Efficiency Matching GPT-5.4

GPT-5.5 introduces enhanced intelligence for complex goals, tool integration, self-verification, and sustained task execution, excelling in agentic coding, computer use, knowledge work, and early scientific research. It matches GPT-5.4's per-token latency while outperforming on evaluations and using fewer tokens for Codex tasks. Full-stack inference optimizations make it faster and more practical for demanding applications in ChatGPT and Codex, now rolling out to paid users including a new Pro variant.

GPT-5.5 Advances Agentic Intelligence with Matching Speed and Higher Efficiency

GPT-5.5 introduces a new intelligence class optimized for complex goals, tool use, self-verification, and multi-step task completion in areas like agentic coding, computer use, knowledge work, and scientific research. It matches GPT-5.4's per-token latency while outperforming on evaluations and using fewer tokens for Codex tasks. Full-stack inference improvements make it faster and more practical for demanding workloads in ChatGPT, rolling out immediately to paid users.

Codex Expands to Universal Mac App Control, Image Generation, and Persistent Automations

Codex now employs macOS computer use to visually control any app via its own cursor for tasks lacking APIs, such as frontend iteration and app testing, while running non-intrusively in the background. It integrates gpt-image-1.5 for in-workflow image generation and iteration, supports 90+ plugins for broader tool access, and enables persistent, schedulable automations that maintain thread context for ongoing tasks. Accessible via ChatGPT accounts without API keys, these features roll out immediately in the Codex desktop app.

Codex Evolves into Universal Mac Workflow Agent with App Control, Image Gen, Memory, and Plugins

Codex now controls Mac apps via visual screen interaction, clicking, and typing with its own cursor for API-less workflows like frontend iteration and app testing. It integrates gpt-image-1.5 for in-flow image generation, supports 90+ plugins, maintains thread context for ongoing automations, and schedules future tasks. All features are accessible via ChatGPT account in the desktop app without API keys, rolling out immediately.

Codex Gains Native Support for Over 90 Plugins Enhancing Tool Integration

OpenAI has integrated support for more than 90 plugins into Codex, expanding its ability to access context and execute actions. This enables seamless interactions with existing tools for document management, project tracking, code review, creative tasks, and deployments. The update broadens Codex's utility across diverse workflows without requiring new tool development.

OpenAI Codex Evolves into Universal Mac Agent with App Control, Tool Integration, and Adaptive Learning

OpenAI's Codex now functions as a comprehensive agent on Mac systems, enabling app usage, expanded tool connections, image creation, action learning, workflow memory, and handling of persistent tasks. This upgrade transforms it into a versatile "Codex for (almost) everything," supporting both one-off and repeatable operations via computer interface. Capabilities emphasize seamless integration with user environments and adaptive personalization.

OpenAI Launches GPT-Rosalind to Accelerate Drug Discovery from 10-15 Years

OpenAI introduces GPT-Rosalind, a frontier reasoning model optimized for biology, drug discovery, and translational medicine, excelling in protein/chemical reasoning, genomics, biochemistry, and scientific tool use. It aims to shorten the 10-15 year drug development timeline by enabling faster hypothesis generation and exploration of possibilities. Available now as research preview via ChatGPT, Codex, and API for select customers like Amgen and Moderna.

AI Accelerates Drug Discovery Beyond Efficiency Gains by Expanding Hypothesis Exploration

Traditional US drug development from target discovery to regulatory approval averages 10-15 years. Advanced AI systems expedite this timeline not only through efficiency in existing workflows but by enabling broader exploration of possibilities, uncovering hidden connections, and generating superior hypotheses faster. This positions AI as a transformative tool in pharmaceutical R&D.

Older entries →